Related Experiment Video
Updated: Jun 3, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Complex decisions in managing HIV infection during pregnancy
Mary A Vogler1, Harjot Singh, Rodney Wright
1Division of Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York Presbyterian Hospital, Center for Special Studies-Rogers Unit, 119 W 24th Street, New York, NY 10011, USA. mav9046@med.cornell.edu
Abstract:
Both the World Health Organization and the United States Department of Health and Human Services have recently substantially revised perinatal HIV treatment guidelines based on emerging data, much of it from the developing world. Management of HIV infection in pregnancy and delivery is complicated by concerns for maternal and fetal drug toxicity, acquisition of antiretroviral resistance, prior therapy, co-infections with other viruses, as well as incident opportunistic infections. Intrapartum and peripartum obstetric management, including the role of Caesarean section, continue to evolve in the setting of maternal HIV infection. Finally, new data have expanded the role of antiviral therapy in allowing safer infant feeding choices for HIV-infected mothers in resource-limited settings.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Cryptococcal Meningitis
Inhibitors of Virion Maturation and Assembly
Pharmacokinetics in Pediatric Patients: Drug Excretion
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
